NASDAQ:MNKD
MannKind Corporation Stock News
$4.39
+0.0100 (+0.228%)
At Close: May 03, 2024
MannKind (MNKD) Reports Q2 Loss, Tops Revenue Estimates
09:15pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
MannKind (MNKD) delivered earnings and revenue surprises of -22.22% and 15.68%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
MannKind (MNKD) Reports Q2 Loss, Tops Revenue Estimates
06:48pm, Tuesday, 09'th Aug 2022
MannKind (MNKD) delivered earnings and revenue surprises of -22.22% and 15.68%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Mersana Therapeutics, Inc. (MRSN) Reports Q2 Loss, Tops Revenue Estimates
09:15pm, Monday, 08'th Aug 2022 Zacks Investment Research
Mersana Therapeutics, Inc. (MRSN) delivered earnings and revenue surprises of -10% and 34.72%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock
Mednax (MD) Q2 Earnings Match Estimates
11:35am, Thursday, 04'th Aug 2022 Zacks Investment Research
Mednax (MD) delivered earnings and revenue surprises of 0% and 1.34%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
United Therapeutics (UTHR) Q2 Earnings Miss Estimates, Revenues Up
04:02pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
United Therapeutics' (UTHR) second-quarter earnings missed estimates, while sales beat the same. Higher sales of Orenitram and Tyvaso drove the top line in the quarter.
MannKind Corporation to Hold 2022 Second Quarter Financial Results Conference Call on August 9, 2022
10:00am, Tuesday, 02'nd Aug 2022 GlobeNewswire Inc.
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will release its 2022 second quarter and year to date financial results and its man
MannKind Corporation to Hold 2022 Second Quarter Financial Results Conference Call on August 9, 2022
06:00am, Tuesday, 02'nd Aug 2022
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will release its 2022 second quarter and year to date financial results and its manag
Why Shares of MannKind Corporation Climbed 10.4% on Monday
11:35pm, Monday, 01'st Aug 2022 The Motley Fool
The company is coming off an FDA approval for its second marketed drug.
Why Shares of MannKind Corporation Climbed 10.4% on Monday
07:35pm, Monday, 01'st Aug 2022
The company is coming off an FDA approval for its second marketed drug.
4 Penny Stocks To Watch After OTRK Stock Explodes Over 140%
03:30pm, Monday, 01'st Aug 2022 PennyStocks
Penny stocks to watch right now.
The post 4 Penny Stocks To Watch After OTRK Stock Explodes Over 140% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
MannKind Corporation to Participate in the BTIG Biotechnology Conference
10:00am, Monday, 01'st Aug 2022 GlobeNewswire Inc.
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative therapeut
What's in Store for United Therapeutics' (UTHR) Q2 Earnings?
02:13pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
United Therapeutics' (UTHR) investor focus is likely to have been on sales figures of Tyvaso, Remodulin and Orenitram in the second quarter, as these constitute a vast majority of the total revenues.
Allogene Therapeutics (ALLO) Moves 16.4% Higher: Will This Strength Last?
01:28pm, Monday, 20'th Jun 2022 Zacks Investment Research
Allogene Therapeutics (ALLO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further pric
Energy stocks are this year's best performers — but they're not on the list of top investment newsletters
11:44am, Saturday, 11'th Jun 2022 MarketWatch
A new sector may soon replace energy at the top of the heap.
Mannkind to Host Product Theater and Booth at the American Diabetes Association’s 82nd Scientific Sessions in New Orleans, June 3-7
02:00pm, Friday, 03'rd Jun 2022 GlobeNewswire Inc.
WESTLAKE VILLAGE, Calif., June 03, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative therapeutic products for pat
